4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-030079
Director disposed of 598,935 shares (other)
- Director acquired 13,413 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Belldegrun Arie · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-05-13 | Other disposition : show line 1 in the form | −598,935 | 4,791,480 | I |
| 2019-05-13 | Other acquisition : show line 2 in the form | +13,413 | 515,076 | I |
Loading xslF345X03/doc4.xml…